Allen SL, Coleman M (1985) Terminal-phase chronic myelogenous leukemia: approaches to treatment. Cancer Invest 3: 491–503
Antimi M, Del Poeta G, Cianculli P, Scimo MT, Stipa E, Venditti A, Catalano GF, Papa G (1988) Plicamycin and hydroxyurea in the treatment of blast phase and accelerated phase of the Ph+ chronic myelogenous leukemia. Abstract. XXII Congress of the International Society of Hematology. Milan, August 28–Sept 2, 1988 and Antimi, M: personal communication.
Gallo JH, McKinley R, Grace CS, Rozenberg MC (1986) Control of acute transformation in chronic granulocytic leukaemia with low-dose cytosine arabinoside (letter). Br J Haematol 61: 586–587
Kantarjian HM, Walters RS, Keating MJ, Talpaz MT, Andersson B, Beran M, McCredie KB, Freireich EJ (1988) Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside. Cancer 62: 672–676
Koller CA, Miller DM (1986) Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med 315: 1433–1438
Spiers ASD (1987) The chronic myeloid leukaemias. In: Whittacker JA, Delaware IW (eds) Leukaemia. Blackwell, Oxford, pp 359–373
Queißer W, Herrmann F, Lindemann F, Anger B, Hiddemann W, Krey U (1988) Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea. Onkologie 11: 145–146
Reiffers J, Gorin NC, Michallet M, Maraninchi D, Herve P (1986) Autografting for chronic granulocytic leukemia in transformation. JNCI 76: 1307–1310
Wiernik SH (1984) The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia. J Clin Oncol 2: 329–335